ICD-10 Coding for Solitary Eruptive Xanthogranuloma(D76.3)
Complete ICD-10-CM coding and documentation guide for Solitary Eruptive Xanthogranuloma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Solitary Eruptive Xanthogranuloma
Key Information: ICD-10 code for solitary eruptive xanthogranuloma
Essential facts and insights about Solitary Eruptive Xanthogranuloma
Primary ICD-10-CM Code for unprotected solitary eruptive xanthogranuloma
Decision Criteria
clinical Criteria
- Presence of Touton giant cells and CD68 positivity
coding Criteria
- Exclude Langerhans cell histiocytosis based on immunohistochemistry
Applicable To
- Solitary Eruptive Xanthogranuloma
Excludes
- Langerhans cell histiocytosis
Clinical Validation Requirements
- Histopathology showing Touton giant cells
- Immunohistochemistry positive for CD68 and factor XIIIa
Code-Specific Risks
- Confusion with Langerhans cell histiocytosis
Coding Notes
- Ensure histopathological confirmation before coding.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Solitary Eruptive Xanthogranuloma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D76.3.
Impact
Clinical: May lead to misdiagnosis., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials.
Mitigation Strategy
Include biopsy results in documentation.
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data reporting.
Mitigation Strategy
Verify immunohistochemical markers to differentiate.
Impact
Lack of detailed histopathological findings.
Mitigation Strategy
Require biopsy confirmation before coding.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Solitary Eruptive Xanthogranuloma, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Solitary Eruptive Xanthogranuloma
Use these documentation templates to ensure complete and accurate documentation for Solitary Eruptive Xanthogranuloma. These templates include all required elements for proper coding and billing.
Dermatology evaluation of xanthogranuloma
Specialty: DermatologyRequired Elements
- Lesion size and location
- Histopathological findings
- Immunohistochemical results
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Solitary Eruptive Xanthogranuloma? Ask your questions below.